Cytek Biosciences Inc (CTKB)
Healthcare
Medical Devices
—
4.20 $
-2.1%
vs. previous close
Closing price · As of: 31. Jul 2026
Cytek Biosciences Inc (CTKB) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -4.7 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| -14 | 15 | 4.6 | -12 | 5.3 | 25 | -4.7 | |
| 0.3 | 0.6 | 1.2 | 5.7 | 9.2 | 10 | 12 | |
| 0.3 | 0.6 | 6.6 | 17 | 22 | 27 | 25 | |
| 1.6 | 2.7 | 7.1 | 17 | – | – | – | |
| 1.2 | -7.5 | -8.6 | -40 | -11 | 7.7 | -4.8 | |
| 1.0 | 1.5 | 4.4 | 9.9 | 4.8 | 3.5 | 4.1 | |
| -1.0 | -1.5 | -21 | -56 | -94 | -83 | 10 | |
| – | – | – | 0.2 | 1.5 | – | – | |
| – | – | 216 | -0.2 | -44 | -22 | -15 | |
| 2.8 | 2.8 | -2.8 | 2.9 | -0.6 | 3.6 | 0.8 | |
| 0.1 | 123 | 214 | 5.5 | -42 | -16 | -13 | |
| -15 | 136 | 198 | -65 | -132 | -69 | -7.9 | |
| -15 | 14 | 0.3 | -22 | 0.5 | 22 | -8.8 |
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.